Fujifilm as a company is most widely associated with photography, but the pandemic and the weakening photo industry overall has changed that. Imaging solutions now makes up just 13% of the company's revenue, and the new CEO is investing heavily in pharmaceuticals as the brand continues to pivot.
White House trade advisor Pete Navarro went on the CNBC show “Squawk Box" this past Monday and ripped into Kodak's executives. Referring to the allegations of insider trading on the eve of the $765 million deal Kodak struck with the US government, Navarro said what happened was "probably the dumbest decisions made by executives in corporate history."
As the world scrambles to find an effective treatment and develop a vaccine for the COVID-19 coronavirus, camera maker Fujifilm's name popped up in the headlines, but it had nothing to do with the cameras or film that they're known for.